FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081051 [Registered on: 21/02/2025] Trial Registered Prospectively
Last Modified On: 08/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to study the effect of Chagaladya Ghrita in patients with Muscle Wasting Disorders.  
Scientific Title of Study   Comparative clinical study to evaluate efficacy of Chagaladya ghrita with resistance exercise in sarcopenia. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vikrant Londhe 
Designation  PG Scholar 
Affiliation  Bharati Vidyapeeth (Deemed to be University) 
Address  Bharati Vidyapeeth (Deemed to be University) College of Ayurved and Hospital Department of Kayachikitsa OPD no 04 Katraj - Dhankawadi Pune

Pune
MAHARASHTRA
411043
India 
Phone  7387505181  
Fax    
Email  vikrant.londhe-ayurved@bvp.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Madhavi Mahajan 
Designation  Professor 
Affiliation  Bharati Vidyapeeth (Deemed to be University) 
Address  Bharati Vidyapeeth (Deemed to be University) College of Ayurved and Hospital Department of Kayachikitsa OPD no 04 Katraj - Dhankawadi Pune

Pune
MAHARASHTRA
411043
India 
Phone  9860124248  
Fax    
Email  madhavi.mahajan@bharatividyapeeth.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Madhavi Mahajan 
Designation  Professor 
Affiliation  Bharati Vidyapeeth (Deemed to be University) 
Address  Bharati Vidyapeeth (Deemed to be University) College of Ayurved and Hospital Department of Kayachikitsa OPD no 04 Katraj - Dhankawadi Pune

Pune
MAHARASHTRA
411043
India 
Phone  9860124248  
Fax    
Email  madhavi.mahajan@bharatividyapeeth.edu  
 
Source of Monetary or Material Support  
Bharati Vidyapeeth college of ayurved and hospital OPD NO 4 AND 2ND FLOOR IPD KATRAJ DHANKAWADI PUNE 411043 
 
Primary Sponsor  
Name  DrVikrant Londhe 
Address  Bharati Vidyapeeth (Deemed to be University) College of Ayurved and Hospital Department of Kayachikitsa OPD no 04 Katraj - Dhankawadi Pune India 411043 
Type of Sponsor  Other [vikrant.londhe-ayurved@bvp.edu.in] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Drvikrant arjun londhe   Bharati Vidyapeeth Deemed to be university college of ayurveda and hospital   Department of kayachikitsa ,OPD no 4 ground floor , IPD 2ND Floor bharati vidyapeeth ayurved hospital
Pune
MAHARASHTRA 
8600186865

vikrant.londhe-ayurved@bvp.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bharati Vidyapeeth Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M959||Acquired deformity of musculoskeletal system, unspecified. Ayurveda Condition: MAMSAKSHAYAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Chagaladya Ghrita, Reference: Bhaishayjya Ratnavali, Route: Oral, Dosage Form: Ghrita, Dose: 20(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: warm water), Additional Information: -
2Comparator Arm (Non Ayurveda)-Resistance exercise The resistance exercise given with thera bands to the person at one time and it will be given for total duration of 60 days
 
Inclusion Criteria  
Age From  60.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patient having age between 60 yrs to 80 yrs irrespective of gender.
SARC F scores more than 4 by 10 
 
ExclusionCriteria 
Details  Uncontrolled diabetes mellitus blood sugar levels are above recommended target ranges
including an HbA1C level above 10.0percent, BSL F more than 200MG per DL , BSL PP more than 300MG per DL
• Uncontrolled hypertension blood pressure that remains above the goal in spite of the
concurrent use of 3 antihypertensive agents of different classes. Ideally, one of the 3 agents
should be a diuretic and all agents should be prescribed at optimal dose amounts.
• Uncontrolled thyroid disease.
• History of serious cerebro cardiovascular diseases , fracture during previous year,
malignancy within 6 months .
• Arthritis, severe enough to prevent completion of the strength testing, history of joint
replacement of knees or hip. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1 Improvement in muscle strength . 2 Improvement in lean muscle mass.
3 Improvement in functional capacity.  
baseline, 15th, 30th, 45th, 60th day folloup  
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in HS CRP level.
• Improvement in body circumference.
• Improvent in quality of life.  
baseline, 15th, 30th, 45th, 60th day folloup  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  01/03/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study will conducted after obtaining permission from institutional ethical community and will be regesistred CTRI india. 
As per inclusion criteria patient will be selected and screening done at OPD and IPD. 
Subjective and Objective parameter will be checked and noted.
Whole research procedure and aim will be clearly informed to patient hence form will be signed by enrolled participant and case report form will be filled 
 
Close